share_log

Citigroup Initiates Coverage On Solid Biosciences With Buy Rating, Announces Price Target of $16

Moomoo 24/7 ·  Mar 15 10:56

Citigroup analyst David Hoang initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment